FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 4110756 · Received September 23, 2014

Report

Report Number
2032227-2014-27947
Event Type
Malfunction
Date Received
September 23, 2014
Date of Event
August 25, 2014
Report Date
August 25, 2014
Manufacturer
MEDTRONIC MINIMED
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WI
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

A COMPLETE ANALYSIS AND TESTING OF THE INSULIN PUMP SHOWED THAT IT WAS FUNCTIONING PROPERLY AND PASSED ALL FUNCTIONAL TESTING. AFTER TESTING IT WAS CONCLUDED THAT THE DEVICE OPERATED WITHIN SPECIFICATIONS. HOWEVER, THE INSULIN PUMP HAD A CRACKED CASE AT A DISPLAY WINDOW CORNER, MINOR SCRATCHES ON THE DISPLAY WINDOW, CRACKED BATTERY TUBE THREADS, CRACKED BELT CLIP SLOT AT THE BATTERY TUBE THREADS AND CRACKED RESERVOIR TUBE LIP.

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE INSULIN PUMP ALARMED SEVERAL MOTOR ERRORS DURING A PRIME ATTEMPT, FOLLOWED BY A NO DELIVERY ALARM. THE BLOOD GLUCOSE READING WAS 321 MG/DL, WHICH THE CUSTOMER TREATED USING THE INSULIN PUMP. NO SIGNIFICANT EVENTS LEADING TO THE ALARM WERE OBSERVED OTHER THAN THE CUSTOMER CHANGING OUT THE INFUSION SET. ADVISED REPLACEMENT OF THE INSULIN PUMP. THE CUSTOMER CALLED BACK TO REPORT A HIGH BLOOD GLUCOSE READING OF 203 MG/DL, WHICH SHE ALSO TREATED WITH THE INSULIN PUMP. NOTHING FURTHER REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
589544 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC MINIMED MMT-723LNAH

Patients

Seq Age Sex Outcome Treatment
1 41 YR